CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)Michael Mian, Sergio Cortelazzo, Alessandro M. Gianni et al.|Annals of Hematology|2010Cited by 34
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Giovanni D’Arena, Idanna Innocenti et al.|Leukemia Research|2015Cited by 31
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric studyMassimiliano Postorino, Maria Cantonetti, Luca Guarnera et al.|Panminerva Medica|2021Cited by 2
Impact Of Bone Marrow Involvement On Outcome Of Young Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL) Treated In The Phase III Randomized Trial (DLCL04) With Rituximab Dose-Dense Chemotherapy Followed By Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Or Standard Rituximab Dose Dense Chemotherapy: A Study of The Fondazione Italiana Linfomi (FIL)Umberto Vitolo, Maurizio Martelli, Annalisa Chiappella et al.|Blood|2013Cited by 0
The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)Sergio Cortelazzo, Emanuele Zucca, Michael Mian et al.|Blood|2008Cited by 0